Studies on the Pathogenesis of Parainfluenza Type 3 Virus Infection in Hamsters

Overview

Journal Arch Gesamte Virusforsch

Specialty Microbiology

Date 1968 Jan 1

PMID 4301657

Citations 8

Authors

C Liu

E Sharp

J Collins

Affiliations

Soon will be listed here.

Citing Articles

Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge.

Park H, Matsuoka Y, Santos C, Luongo C, Liu X, Yang L bioRxiv. 2024; .

PMID: 39372768 PMC: 11451599. DOI: 10.1101/2024.09.12.612598.

Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.

Afroz S, Saul S, Dai J, Surman S, Liu X, Park H Proc Natl Acad Sci U S A. 2024; 121(25):e2316376121.

PMID: 38861603 PMC: 11194498. DOI: 10.1073/pnas.2316376121.

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

Liesman R, Buchholz U, Luongo C, Yang L, Proia A, DeVincenzo J J Clin Invest. 2014; 124(5):2219-33.

PMID: 24713657 PMC: 4001550. DOI: 10.1172/JCI72948.

A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine.

Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T Vaccine. 2013; 31(52):6239-46.

PMID: 24144478 PMC: 11774192. DOI: 10.1016/j.vaccine.2013.10.029.

Effect of poly I: C on experimental respiratory infection in hamsters.

RENIS H Appl Microbiol. 1970; 20(5):821-4.

PMID: 4320866 PMC: 377055. DOI: 10.1128/am.20.5.821-824.1970.

References

Coons A, LEDUC E, Kaplan M . Localization of antigen in tissue cells. VI. The fate of injected foreign proteins in the mouse. J Exp Med. 1951; 93(2):173-88. PMC: 2136059. DOI: 10.1084/jem.93.2.173. View

WELLER T, Coons A . Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med. 1954; 86(4):789-94. DOI: 10.3181/00379727-86-21235. View

PARROTT R, VARGOSKO A, KIMHW , Bell J, Chanock R . Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses. Am J Public Health Nations Health. 1962; 52:907-17. PMC: 1523067. DOI: 10.2105/ajph.52.6.907. View

DICK E, MOGABGAB W, Holmes B . Characteristics of para-influenza 1 (HA-2) virus. I. Incidence of infection and clinical features in adults. Am J Hyg. 1961; 73:263-72. DOI: 10.1093/oxfordjournals.aje.a120185. View

Craighead J, COOK M, Chanock R . Infection of hamsters with para influenza 3 virus. Proc Soc Exp Biol Med. 1960; 104:301-4. DOI: 10.3181/00379727-104-25816. View

Riggs J, SEIWALD R, BURCKHALTER J, DOWNS C, Metcalf T . Isothiocyanate compounds as fluorescent labeling agents for immune serum. Am J Pathol. 1958; 34(6):1081-97. PMC: 1934794. View

COOK M, Andrews B, FOX H, Turner H, James W, Chanock R . Antigenic relationships among the newer myxoviruses (parainfluenza). Am J Hyg. 1959; 69(3):250-64. DOI: 10.1093/oxfordjournals.aje.a119998. View

Cohen S, Bullivant S, Edwards G . A morphologic study of FL cells infected with para-influenza 3 virus. Arch Gesamte Virusforsch. 1962; 11:493-515. DOI: 10.1007/BF01241303. View

Wenner H, Miller C, KAMITSUKA P, Wilson J . Preparation and standardization of antiserums prepared with the three known types to poliomyelitis viruses. Am J Hyg. 1954; 59(2):221-35. DOI: 10.1093/oxfordjournals.aje.a119635. View

10.

Liu C . A study of measles virus infection in tissue culture cells with particular reference to the development of intranuclear inclusion bodies. J Immunol. 1965; 95(5):840-5. View

11.

. AGGLUTINATION-INHIBITION test proposed as a standard of reference in influenza diagnostic studies; Committee on Standard Serological Procedures in Influenza Studies. J Immunol. 1950; 65(3):347-53. View

12.

Gifford G, TOY S, Lindenmann J . Studies on vaccinia virus plaque formation and its inhibition by interferon. II. Dynamics of plaque formation by vaccinia virus in the presence of interferon. Virology. 1963; 19:294-301. DOI: 10.1016/0042-6822(63)90067-9. View

13.

Chanock R, PARROTT R, Johnson K, Kapikian A, Bell J . MYXOVIRUSES: PARAINFLUENZA. Am Rev Respir Dis. 1963; 88:SUPPL 152-66. DOI: 10.1164/arrd.1963.88.3P2.152. View

14.

Traver M, Northrop R, Walker D . Site of intracellular antigen production by myxoviruses. Proc Soc Exp Biol Med. 1960; 104:268-73. DOI: 10.3181/00379727-104-25803. View

15.

Maassab H, Loh P . Fluorescent antibody studies in tissue culture of parainfluenza 3 infection. Proc Soc Exp Biol Med. 1962; 109:897-900. DOI: 10.3181/00379727-109-27371. View

16.

Johnson K, Chanock R, COOK M, HUEBNER R . Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. Am J Hyg. 1960; 71:81-92. DOI: 10.1093/oxfordjournals.aje.a120092. View

17.

Hanson R, KEMPF J, BOAND Jr A . Phagocytosis of influenza virus. II. Its occurrence in normal and immune mice. J Immunol. 1957; 79(5):422-7. View

18.

Liu C . Studies on influenza infection in ferrets by means of fluorescein-labelled antibody. II. The role of soluble antigen in nuclear fluorescence and cross-reactions. J Exp Med. 1955; 101(6):677-86. PMC: 2136485. DOI: 10.1084/jem.101.6.677. View

19.

COOK M, Chanock R . In vivo antigenic studies of parainfluenza viruses. Am J Hyg. 1963; 77:150-9. DOI: 10.1093/oxfordjournals.aje.a120304. View